Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma (2017)
- Authors:
- USP affiliated authors: KALIL FILHO, ROBERTO - FM ; MARANHAO, RAUL CAVALCANTE - FCF
- Unidades: FM; FCF
- DOI: 10.1007/s12032-017-1009-z
- Subjects: NANOPARTÍCULAS; CARCINOMA; OVÁRIO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Medical Oncology
- ISSN: 1357-0560
- Volume/Número/Paginação/Ano: v. 34, p. 1-7 art. 151, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
GRAZIANI, Silvia Regina et al. Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma. Medical Oncology, v. 34, p. 1-7 art. 151, 2017Tradução . . Disponível em: https://doi.org/10.1007/s12032-017-1009-z. Acesso em: 19 abr. 2024. -
APA
Graziani, S. R., Vital, C. G., Morikawa, A. T., Eyll, B. M. V., Fernandes Júnior, H. J., Kalil Filho, R., & Maranhão, R. C. (2017). Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma. Medical Oncology, 34, 1-7 art. 151. doi:10.1007/s12032-017-1009-z -
NLM
Graziani SR, Vital CG, Morikawa AT, Eyll BMV, Fernandes Júnior HJ, Kalil Filho R, Maranhão RC. Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma [Internet]. Medical Oncology. 2017 ; 34 1-7 art. 151.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s12032-017-1009-z -
Vancouver
Graziani SR, Vital CG, Morikawa AT, Eyll BMV, Fernandes Júnior HJ, Kalil Filho R, Maranhão RC. Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma [Internet]. Medical Oncology. 2017 ; 34 1-7 art. 151.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s12032-017-1009-z - Efeito do tratamento do metotrexato associado à nanopartícula de LDE na miocardiopatia diabética induzida por streptozotocina em ratos
- Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects
- Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions
- Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model
- Regression of atherosclerosis plaques of cholesterol-fed rabbits by combined chemotherapy of paclitaxel and methotrexate carried in lipid core nanoparticles
- Removal of chylomicron remnants from the bloodstream is delayed in aged subjects
- Effects of short-term hypothyroidism on the lipid transfer to high-density lipoprotein and other parameters related to lipoprotein metabolism in patients submitted to thyroidectomy for thyroid cancer
- Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model
- Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model
- Alterações no metabolismo e função da Lipoproteína de alta densidade (HDL) em pacientes com doença arterial obstrutiva periférica: implicações para prevenção e tratamento
Informações sobre o DOI: 10.1007/s12032-017-1009-z (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
